SOLARA, NCT04711824: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
|
|
| Recruiting | 1/2 | 41 | US | Olaparib, Lynparza, Stereotactic Radiosurgery, SRS, Durvalumab, Imfinzi, Physicians Choice systemic chemotherapy, Paclitaxel, Nab-paclitaxel, Eribulin, Carboplatin, Cisplatin, Capecitabine, Gemcitabine | Colette Shen, AstraZeneca, University of North Carolina, Chapel Hill | Breast Cancer, Brain Metastases, Adult | 11/25 | 11/26 | | |
